323 Immunogenic syngeneic model MC38-OVA for the preclinical evaluation of immune evasion and checkpoint blockade von Wang, Jessie, Lian, Kaixia, Zheng, Jia, Nie, Chenpan, An, Annie, Li, Henry

Volltext

Abstract A009: Establishment and application of a series of systemic bioluminescent hematologic cell line derived xenograft models von Song, Yanrui, Nie, Chenpan, Yang, Tao, Yin, Yinfei, Li, Henry Qixiang, Ouyang, Davy Xuesong

Volltext

Abstract 5615: Anti-human CD47 antibody Hu5F9 inhibits MC38 tumor growth in hCD47/hSIRPα double knock-in mice von He, Daniel Xianfei, Nie, Chenpan, Zheng, Lei, Sun, Ruilin, An, Annie Xiaoyu, Li, Henry Q. x., Ouyang, Davy Xuesong

Volltext

Abstract 5614: Combination of anti-TIGIT and anti-PD-1 antibodies enhance antitumor response in a PD-1/TIGIT double HuGEMM™ model engrafted with mouse syngeneic tumors von He, Daniel Xianfei, Nie, Chenpan, Zheng, Lei, Sun, Ruilin, Zhang, Mingkun, An, Annie Xiaoyu, Ju, Cunxiang, Li, Henry Q. X., Ouyang, Davy Xuesong

Volltext

Abstract 5118: STING agonist and TLR7/8 agonist overcome anti-PD-1 resistance mediated by loss of β2M von Hua, Li, Nie, Chenpan, Lin, Jie, An, Annie Xiaoyu, Bourre, Ludovic, Wang, Jingjing

Volltext

Abstract 4221: Characterization of OVA-expressing immunogenic syngeneic tumor models for immune checkpoint inhibitor evaluation von Nie, Chenpan, Zhang, Yi, Zheng, Jia, An, Annie X., Zhou, Jun, Li, Henry Q.X., Wang, Jingjing

Volltext

Abstract 617: MEK inhibitor rescued the efficacy of PD-1 blocker in STK11/LKB1 mutated colorectal cancer model von Liu, Demi X., Zhou, Jun, Nie, Chenpan, An, Annie X., Li, Henry Q.X., Wang, Jingjing

Volltext

Abstract 401: Developing KRAS G12C inhibitor-resistant tumor models for efficacy evaluation of next-generation anticancer therapies von Zhou, Jun, Ye, Zi, Bo, Ning, Zhang, Dan, Hua, Li, Nie, Chenpan, Wang, Jingjing, Kumari, Rajendra, Price, Leo, Xu, Xiaoxi

Volltext

合并视网膜大血管阻塞的系统性红斑狼疮的临床观察 von 陈乔 聂尚武 王晓琴 陈盼

Volltext